Enovis to Report Q4 After $548.9M Revenue Beat, Forecasting 4.1% Growth
Enovis will report fourth-quarter results tomorrow after posting $548.9 million in revenue last quarter, up 8.6% year over year, with both revenue and EPS beating analyst estimates. Analysts forecast Q4 revenue growth of 4.1% year over year, down sharply from the 23.3% rise in the same quarter a year ago.
1. Earnings Preview
Enovis is scheduled to release its fourth-quarter results before the market opens tomorrow, offering insight into whether the company can sustain its recent momentum in its medical technology segment.
2. Prior Quarter Performance
In the previous quarter, Enovis generated $548.9 million in revenue, representing an 8.6% year-over-year increase and surpassing both revenue and EPS analyst forecasts.
3. Q4 Expectations
For Q4, the consensus calls for 4.1% year-over-year revenue growth, a significant deceleration from the 23.3% increase recorded in the same period last year; analysts have mostly maintained their estimates ahead of the report.
4. Peer Results And Sector Trends
Peer Globus Medical delivered 25.7% revenue growth with a 3.2% beat, while Haemonetics saw a 2.7% decline but topped estimates by 2.4%, as the specialty medical device segment’s average share price dipped 1.1% over the past month.